Phase 3 AstraZeneca Coronavirus Vaccine Study Reopens at URMC
The University of Rochester Medical Center is joining a phase 3 clinical trial for a potential coronavirus vaccine being developed by AstraZeneca and the University of Oxford known as AZD1222.